Leukemia Clinical Trials | Norton Healthcare Louisville, Ky.

Leukemia Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

Learn more about participating in a clinical trial at Norton Healthcare.

Acute Myeloid Leukemia (AML)

Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (? 60 […]

Acute Myeloid Leukemia (AML)

Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second or Third Salvage

Chronic Lymphocytic Leukemia (CLL)

A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304

Chronic Lymphocytic Leukemia (CLL)

A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated […]

Chronic Lymphocytic Leukemia (CLL)

ULTRA-V: Phase 2 Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax (U2-V) in Subjects with Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Leukemia

A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study of Pracinostat in Combination with Azacitidine in Patients ?18 Years with Newly Diagnosed Acute Myeloid Leukemia unfit for Standard Induction Chemotherapy

Leukemia

A Multicenter, Open-Label Phase 1b Study to Assess Safety and Efficacy of Venetoclax in Combination with Gilteritinib in Subjects with Relapsed/Refractory Acute Myeloid Leukemia.

Lymphoma

A PHASE 1/2A OPEN-LABEL, MULTI-DOSE, MULTI-CENTER ESCALATION AND EXPLORATORY STUDY OF CERDULATINIB(PRT062070) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) OR B-CELL or T-CELL NON-HODGKIN LYMPHOMA (NHL)

Myeloproliferative Neoplasms

SL-401 in Patients With Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Primary Eosinophilic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Brain tumor treatment gives Southern Indiana man new perspective on caring and compassion

(The caring team from Norton Brownsboro Hospital, from left to right: Catherine Tomes, RN, Autumn Chapman, RN, Regina Green, RN, Amanda Kroeger, PCA, Jessica Lesousky, RN, Aster Mehari, RN.) A conversation with 66-year-old Bobby Rogers […]

Read Full Story

Radon is a dangerous carcinogen and a particular risk in Jefferson, Bullitt and Nelson counties

Radon is a dangerous carcinogen. The odorless, invisible gas is the No. 1 cause of lung cancer among nonsmokers and the No. 2 cause of lung cancer deaths. The radioactive gas seeps out of the […]

Read Full Story

Nurse is advocate for her patients diagnosed with cancer

Deborah Pirtle, R.N., oncology patient navigator with Norton Cancer Institute, firmly believes that one day there will be a cure for cancer. Until then, she is dedicated to advocating for her patients. “Every person has […]

Read Full Story

Women’s cancer facilities and specialized urgent care part of renovation

Renovations underway at Norton Cancer Institute – Downtown and nearby facilities will expand and relocate many cancer subspecialties. Completion is planned for February 2020, with two downtown campus locations getting a makeover. Norton Cancer Institute […]

Read Full Story

Churchill Downs named Philanthropist of the Year – Organization

In 2017, Churchill Downs named the Norton Healthcare Foundation its charitable beneficiary of the Kentucky Oaks. Over the past year, Churchill Downs raised more than $75,000 to benefit breast health at Norton Cancer Institute, specifically […]

Read Full Story
Related Stories

Brain tumor treatment gives Southern Indiana man new perspective on caring and compassion

(The caring team from Norton Brownsboro Hospital, from left to right: Catherine Tomes, RN, Autumn Chapman, RN, Regina Green, RN, Amanda Kroeger, PCA, Jessica Lesousky, RN, Aster Mehari, RN.) A conversation with 66-year-old Bobby Rogers […]

Read Full Story

Radon is a dangerous carcinogen and a particular risk in Jefferson, Bullitt and Nelson counties

Radon is a dangerous carcinogen. The odorless, invisible gas is the No. 1 cause of lung cancer among nonsmokers and the No. 2 cause of lung cancer deaths. The radioactive gas seeps out of the […]

Read Full Story

Nurse is advocate for her patients diagnosed with cancer

Deborah Pirtle, R.N., oncology patient navigator with Norton Cancer Institute, firmly believes that one day there will be a cure for cancer. Until then, she is dedicated to advocating for her patients. “Every person has […]

Read Full Story

Women’s cancer facilities and specialized urgent care part of renovation

Renovations underway at Norton Cancer Institute – Downtown and nearby facilities will expand and relocate many cancer subspecialties. Completion is planned for February 2020, with two downtown campus locations getting a makeover. Norton Cancer Institute […]

Read Full Story

Churchill Downs named Philanthropist of the Year – Organization

In 2017, Churchill Downs named the Norton Healthcare Foundation its charitable beneficiary of the Kentucky Oaks. Over the past year, Churchill Downs raised more than $75,000 to benefit breast health at Norton Cancer Institute, specifically […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.